FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Jubilant Cadista Pharmaceuticals Methylprednisolone Tablets Recall

Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jublia…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class III
Reported by FDA
Apr 13, 2022
Recall ID
D-0752-2022
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Methylprednisolone Tablets starting Apr 1, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0752-2022 on Apr 13, 2022. Reason: Subpotent. Status: Terminated.

Why it was recalled

Subpotent

Product description

Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06

Lot numbers, UPCs & expiration codes

Lot # 21 P0322, Exp. 01/2023

Where it was sold

Nationwide in the USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0752-2022
Classification
Class III
Status
Terminated
Recall initiated
Apr 1, 2022
FDA report date
Apr 13, 2022
Quantity
19,222 Bottles (100-count)
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0752-2022, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
89923
Address
207 Kiley Dr
Code information
Lot # 21 P0322, Exp. 01/2023
Postal code
21801-2249
Report date
Apr 13, 2022
Product type
Drugs
Recall number
D-0752-2022
Classification
Class III
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
19,222 Bottles (100-count)
Termination date
Apr 3, 2023
Reason for recall
Subpotent
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06
Distribution pattern
Nationwide in the USA and Puerto Rico
Recall initiation date
Apr 1, 2022
Initial firm notification
Letter
Center classification date
Apr 6, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0752-2022, published Apr 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls